This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Maltodextrin
- DrugBank Accession Number
- DB12583
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Re-action E Maltodextrin (0.012 g/0.4g) + Aloe vera leaf (0.0007 g/0.4g) + Bambusa arundinacea stem (0.04 g/0.4g) + Caffeine (0.0008 g/0.4g) Powder Topical Goldeneye Permanent System GmbH Germany 2018-07-27 Not applicable US 
- Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Re-action E Maltodextrin (0.012 g/0.4g) + Aloe vera leaf (0.0007 g/0.4g) + Bambusa arundinacea stem (0.04 g/0.4g) + Caffeine (0.0008 g/0.4g) Powder Topical Goldeneye Permanent System GmbH Germany 2018-07-27 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 7CVR7L4A2D
- CAS number
- 9050-36-6
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- Not Available
- External Links
- PubChem Substance
- 347911346
- 1363050
- Wikipedia
- Maltodextrin
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Atopic Dermatitis 1 4 Completed Treatment Obesity / Resistance, Insulin 1 4 Not Yet Recruiting Prevention Left Ventricular Dysfunction / Quality of Recovery / Ventricular Dysfunction, Right 1 4 Not Yet Recruiting Treatment Cirrhosis of the Liver / Muscle Cramps / Quality of Life (QOL) 1 4 Withdrawn Treatment Depression 1 3 Completed Prevention Cancer / Diarrhea 1 3 Completed Treatment Sickle Cell Anemia / Sickle ß0-Thalassemia 1 2 Completed Treatment Insulin Sensitivity 2 2 Completed Treatment Sickle Cell Anemia / Thalassemia 1 2 Completed Treatment Slow Transit Constipation 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Powder Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at October 20, 2016 23:01 / Updated at June 12, 2020 16:53